The Role of CD2 in Acute Rejection after Small Bowel Transplantation in Rats

季刚,林艳,王为忠,管文贤,牛卫博
DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2006.01.014
2006-01-01
Abstract:Objective To investigate the expression of CD2 in peripheral blood T lymphocytes in acute rejection after small bowel transplantation (SBT) in rats.Methods Three groups were set up: Group A (n=18), receiving sham operation and feeding of common feedstuff; Group B (n=18) receiving SD rat to SD rat iso-series SBT and the treatment of routine liquid infusion and antibiotics after operation; Group C (n=18) receiving SD rat to Wistar rat taniso-series SBT and the same post- operation treatments as in group B. Samples of grafts and peripheral blood in the three groups were collected on the day 3, 5 and 7 respectively after SBT for detection of flow cytometry. The intestinal grafts were obtained for pathological examination.Results The survival time of rats in group C, group B and group A was 7.0± 2.1, 33.3± 2.3 and more than 90 days, respectively. There was significant difference between group C and groups A, B (P 0.05). The percentage of CD2 positive T lymphocytes in peripheral blood 3, 5 and 7 days after operation was 70.2 %, 69.8 % and 70.3 % in group A, 71.3 %, 69.7 % and 70.2 % in group B and 95.6 %, 88.1 % and 81.2 % in group C respectively. The percentage of CD2 positive T lymphocytes in group C was significantly higher than that in groups A and B (P 0.05). The pathological changes of the intestinal grafts in group C were observed and gradually deteriorated with the postoperative time over.Conclusion A sudden rise of the CD2 positive T lymphocytes intensively suggested the occurrence of acute rejection after SBT and could be thought of as one of immune markers which can predict the occurrence of acute rejection in the early stage.
What problem does this paper attempt to address?